In re Galena Biopharma, Inc. Securities Litigation
UNITED STATES DISTRICT COURT
DISTRICT OF OREGON
All Persons and Entities that purchased Galena Biopharma, Inc., (“Galena”) common stock during the class period from August 6, 2013 through May 14, 2014, both dates inclusive (the "Class Period”). Excluded From the Class Are Defendants, The Officers and Directors of Galena, and their Families and Affiliates. YOUR RIGHTS MAY BE AFFECTED BY Legal Proceedings in this Litigation.
If you are a member of the class described above, you may be entitled to receive a payment pursuant to the proposed settlement. To claim your share of the Settlement Fund, you must submit a valid Proof of Claim and Release Form postmarked on or before April 16, 2016. The Notice explains the lawsuit, the Settlement, the Plan of Allocation, your legal rights, what benefits are available, who is eligible for them, and how to receive them.
SPECIAL NOTICE TO BROKERS AND OTHER NOMINEES
Brokerage firms, banks, financial institutions and other nominees (“Nominees”) who, during the Class Period, purchased or sold Galena common stock, CUSIP #363256108 in the name of the Nominees on behalf of beneficial owners of such securities who may be members of the Class, are requested to provide the Claims Administrator with the name and last known address of each such person or entity for whom the Nominee executed such transactions, preferably in an MS Excel data table setting forth: (1) title/registration, (2) street address, (3) city/state/zip. The Claims Administrator will then cause the Notice and Proof of Claim to be mailed promptly to said beneficial owners. Alternatively, Nominees may request additional copies of this Notice and the Proof of Claim from the Claims Administrator, in which case the Nominees are required to promptly mail the Notice and Proof of Claim Form directly to the persons for whom, the transactions were made and provide the Claims administrator with written confirmation of having done so. For either alternative, contact the Claims Administrator by email at nominees@GalenaSecuritiesLitigation.com.
After receipt of a timely request for reimbursement and supporting documentation, the Claims Administrator will reimburse the Nominee for all costs reasonably incurred in gathering and forwarding the names and addresses of the beneficial owners to the Claims Administrator, or forwarding the Notice and Proof of Claim to beneficial owners, as the case may be, up to $0.75 per Notice.